Andrew James King Chinook Therapeutics, Inc. (KDNY) insider trading activity

KDNY Quotes by TradingView

Andrew James King is Chief Scientific Officer of CHINOOK THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of KDNY, which is worth approximately $0. The most recent transaction as insider was on Nov 09, 2021, when has been sold 2,500 shares (Common Stock) at a price of $0.35 per share, resulting in proceeds of $875. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Andrew James King Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 09 2021
BUY
Exercise of conversion of derivative security
$875 $0.35 p/Share
2,500 Added 21.56%
9,094 Common Stock
Oct 06 2021
SELL
Payment of exercise price or tax liability
$44,000 $12.37 p/Share
3,557 Reduced 35.04%
6,594 Common Stock
Oct 06 2021
BUY
Exercise of conversion of derivative security
-
10,151 Added 50.0%
10,151 Common Stock
AJK

Andrew James King

Chief Scientific Officer
Seattle, WA

Track Institutional and Insider Activities on KDNY

Follow CHINOOK THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KDNY shares.

Notify only if

Insider Trading

Get notified when an Chinook Therapeutics, Inc. insider buys or sells KDNY shares.

Notify only if

News

Receive news related to CHINOOK THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KDNY